Sutter Health/Sutter Roseville Medical Center
Hematology and Oncology fellowship · Roseville, CA · Program website
Internal Medicine residency here · Other fellowships: Cardiovascular Disease · Gastroenterology · Pulmonary and Critical Care
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is Sutter Health's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
Hematology and Oncology at Sutter Healthshared by every program there, not this program's own
Institution-level: all hematology and oncology publications from Sutter Health + Sutter Roseville Medical Center and affiliated institutions, since 2022. Updated 2026-11-08; refreshed daily.
Works per year · * 2026 so far
Hematology and Oncology research topics at Sutter Health
Papers in the window; each links to the list on OpenAlex.
- Ovarian cancer diagnosis and treatment 37
- Cutaneous Melanoma Detection and Management 32
- Cancer Immunotherapy and Biomarkers 21
- Global Cancer Incidence and Screening 21
- PARP inhibition in cancer therapy 17
- Glioma Diagnosis and Treatment 9
- Cancer Risks and Factors 8
- Colorectal Cancer Screening and Detection 7
Most cited at Sutter Health since 2024
All hematology and oncology papers there on OpenAlex
- Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 StudyMuhammad Adnan Khattak et al. · Journal of Clinical Oncology · 2026 · PubMed · cited 32
- Cutaneous MelanomaUrvashi Mitbander Joshi et al. · JAMA · 2025 · PubMed · cited 68
- Psychosocial impact associated with a multicancer early detection test (PATHFINDER): a prospective, multicentre, cohort studyLincoln D. Nadauld et al. · The Lancet Oncology · 2025 · PubMed · cited 19
- Depicting Biomarkers for HER2-Inhibitor Resistance: Implication for Therapy in HER2-Positive Breast CancerAlvan Cai et al. · Cancers · 2024 · PubMed · cited 15
- Cancer metastasis through the lymphatic versus blood vesselsStanley P. L. Leong et al. · Clinical & Experimental Metastasis · 2024 · PubMed · cited 60
- Phase I Study of Fianlimab, a Human Lymphocyte Activation Gene-3 (LAG-3) Monoclonal Antibody, in Combination With Cemiplimab in Advanced MelanomaOmid Hamid et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 42
- Talazoparib in Patients With Solid Tumors With BRCA1/2 Mutation: Results From the Targeted Agent and Profiling Utilization Registry StudyGordan Srkalović et al. · JCO Precision Oncology · 2024 · PubMed · cited 14
- Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the GameKimberly S. Ku et al. · International Journal of Molecular Sciences · 2024 · PubMed · cited 18
- A multicenter prospective study to define the natural history of BK viral infections in kidney transplantationMichael E. Seifert et al. · Transplant Infectious Disease · 2024 · PubMed · cited 16
- Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b studyJeffrey S. Weber et al. · The Lancet · 2024 · PubMed · cited 974
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/sutter-health-sutter-roseville-medical-center-heme-onc"><img src="https://openprograms.org/programs/sutter-health-sutter-roseville-medical-center-heme-onc/badge.svg" alt="Sutter Health/Sutter Roseville Medical Center Hematology and Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.